Skip to main content
UNCY logo
UNCY
(NASDAQ)
Unicycive Therapeutics, Inc.
$8.21-- (--)
Loading... - Market loading

Unicycive Therapeutics (UNCY) Stock Price & Financial Analysis

Unicycive Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.66 - $7.33
52-Week High$8.74
52-Week Low$3.71
Open$7.20
Volume1.48M
Average Volume (3M)815.63K
Market Cap1.64B
Shares Outstanding239.08M
Price to Book (P/B)43.44
EV/EBITDA-40.26
50-Day MA$7.44
200-Day MA$6.15
52-Week Change2.62%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Unicycive Therapeutics

What is the current stock price for UNCY?

As of the latest trading session, UNCY stock trades at $6.85. The 52-week range is $3.71–$8.74, with a day range of $6.66–$7.33.

What is the P/E ratio for UNCY?

The P/E ratio (Price-to-Earnings) for UNCY is shown in the Key Statistics section. This valuation metric helps compare Unicycive Therapeutics, Inc. to industry peers.

Does UNCY pay dividends?

Unicycive Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for UNCY?

Based on 7 analysts, the consensus for UNCY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of UNCY?

Unicycive Therapeutics's market capitalization is $1.64B, classifying it as a small-cap company. Unicycive Therapeutics operates in the Healthcare sector within the Biotechnology industry.